Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) (346550)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Sep 5, 2023 (Letter of inquiry)

Later deadlines: Oct 5, 2023 (Full proposal), Jan 5, 2024 (Letter of inquiry), Feb 5, 2024 (Full proposal), May 5, 2024 (Letter of inquiry), Jun 5, 2024 (Full proposal), Sep 5, 2024 (Letter of inquiry), Oct 5, 2024 (Full proposal), Jan 5, 2025 (Letter of inquiry), Feb 5, 2025 (Full proposal), May 5, 2025 (Letter of inquiry), Jun 5, 2025 (Full proposal), Sep 5, 2025 (Letter of inquiry), Oct 5, 2025 (Full proposal), Jan 5, 2026 (Letter of inquiry), Feb 5, 2026 (Full proposal)

Grant amount: Unspecified amount

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization.

The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to:

• advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact;
• enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and 
• discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating persons, neonates, and children.

The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating persons, fetuses, neonates, and children, including those with disabilities.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.